Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
B-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium mo...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:743e07eb15f3482aad46de745f21ea6c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:743e07eb15f3482aad46de745f21ea6c2021-11-20T04:57:05ZPlasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia1319-562X10.1016/j.sjbs.2021.08.044https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21007324https://doaj.org/toc/1319-562XB-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI), B-cell maturation antigen (BCMA), and B-cell activating factor receptor (BAFF-R). Herein, we assessed the plasma protein levels of BAFF and APRIL in patients with asthma to determine whether their expression is correlated with total IgE production and examined the surface expression of BAFF/APRIL receptors on B cells. Blood samples were collected from 47 patients with controlled asthma symptoms and 20 healthy normal controls, and plasma levels of APRIL, BAFF, and total IgE protein were quantified by corresponding ELISA assays. Furthermore, lymphocytes were isolated and B cells were analyzed for the presence of BAFF-R, BCMA, and TACI receptors using flow cytometry. Our results showed that IgE, BAFF, and APRIL plasma levels were markedly increased in patients with asthma compared with healthy controls. Moreover, expression of BAFF-R and BCMA, but not that of TACI, was significantly increased in patients with asthma compared with healthy controls. Overall, the findings suggest BAFF and APRIL as key mediators of asthma, and determination of their plasma levels may be useful in monitoring asthma symptoms and treatment response.Wael AlturaikiAyman MubarakSajad Ahmad MirAdnan AfridiMariappan PremanathanSuresh MickymarayRajendran VijayakumarSuliman A. AlsagabySami G. AlmalkiFayez AlghofailiAhmad K. AlnemareBrian F. FlanaganElsevierarticleAsthmaIgEB cellBAFFAPRILBiology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7455-7459 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Asthma IgE B cell BAFF APRIL Biology (General) QH301-705.5 |
spellingShingle |
Asthma IgE B cell BAFF APRIL Biology (General) QH301-705.5 Wael Alturaiki Ayman Mubarak Sajad Ahmad Mir Adnan Afridi Mariappan Premanathan Suresh Mickymaray Rajendran Vijayakumar Suliman A. Alsagaby Sami G. Almalki Fayez Alghofaili Ahmad K. Alnemare Brian F. Flanagan Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
description |
B-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI), B-cell maturation antigen (BCMA), and B-cell activating factor receptor (BAFF-R). Herein, we assessed the plasma protein levels of BAFF and APRIL in patients with asthma to determine whether their expression is correlated with total IgE production and examined the surface expression of BAFF/APRIL receptors on B cells. Blood samples were collected from 47 patients with controlled asthma symptoms and 20 healthy normal controls, and plasma levels of APRIL, BAFF, and total IgE protein were quantified by corresponding ELISA assays. Furthermore, lymphocytes were isolated and B cells were analyzed for the presence of BAFF-R, BCMA, and TACI receptors using flow cytometry. Our results showed that IgE, BAFF, and APRIL plasma levels were markedly increased in patients with asthma compared with healthy controls. Moreover, expression of BAFF-R and BCMA, but not that of TACI, was significantly increased in patients with asthma compared with healthy controls. Overall, the findings suggest BAFF and APRIL as key mediators of asthma, and determination of their plasma levels may be useful in monitoring asthma symptoms and treatment response. |
format |
article |
author |
Wael Alturaiki Ayman Mubarak Sajad Ahmad Mir Adnan Afridi Mariappan Premanathan Suresh Mickymaray Rajendran Vijayakumar Suliman A. Alsagaby Sami G. Almalki Fayez Alghofaili Ahmad K. Alnemare Brian F. Flanagan |
author_facet |
Wael Alturaiki Ayman Mubarak Sajad Ahmad Mir Adnan Afridi Mariappan Premanathan Suresh Mickymaray Rajendran Vijayakumar Suliman A. Alsagaby Sami G. Almalki Fayez Alghofaili Ahmad K. Alnemare Brian F. Flanagan |
author_sort |
Wael Alturaiki |
title |
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
title_short |
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
title_full |
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
title_fullStr |
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
title_full_unstemmed |
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia |
title_sort |
plasma levels of baff and april are elevated in patients with asthma in saudi arabia |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c |
work_keys_str_mv |
AT waelalturaiki plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT aymanmubarak plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT sajadahmadmir plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT adnanafridi plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT mariappanpremanathan plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT sureshmickymaray plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT rajendranvijayakumar plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT sulimanaalsagaby plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT samigalmalki plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT fayezalghofaili plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT ahmadkalnemare plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia AT brianfflanagan plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia |
_version_ |
1718419722085597184 |